Growth • Leap Therapeutics
CYPH
Cypherpunk Technologies Inc is a company developing novel therapies for patients with cancer and implementing a digital asset treasury plan focused on Zcash.
-100%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
12,8%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
13,1%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-28%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
15,3%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!